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Cranial neural tube defects (NTDs) occur in mice carrying mutant alleles of many different genes, whereas
isolated spinal NTDs (spina biﬁda) occur in fewer models, despite being common human birth defects.
Spina biﬁda occurs at high frequency in the Axial defects (Axd) mouse mutant but the causative gene is
not known. In the current study, the Axd mutation was mapped by linkage analysis. Within the critical geno-
mic region, sequencing did not reveal a coding mutation whereas expression analysis demonstrated signiﬁ-
cant up-regulation of grainyhead-like 2 (Grhl2)i nAxd mutant embryos. Expression of other candidate genes
did not differ between genotypes. In order to test the hypothesis that over-expression of Grhl2 causes Axd
NTDs, we performed a genetic cross to reduce Grhl2 function in Axd heterozygotes. Grhl2 loss of function
mutant mice were generated and displayed both cranial and spinal NTDs. Compound heterozygotes carrying
both loss (Grhl2 null) and putative gain of function (Axd) alleles exhibited normalization of spinal neural tube
closure compared with Axd/1 littermates, which exhibit delayed closure. Grhl2 is expressed in the surface
ectoderm and hindgut endoderm in the spinal region, overlapping with grainyhead-like 3 (Grhl3). Axd
mutants display delayed eyelid closure, as reported in Grhl3 null embryos. Moreover, Axd mutant embryos
exhibited increased ventral curvature of the spinal region and reduced proliferation in the hindgut, reminis-
cent of curly tail embryos, which carry a hypomorphic allele of Grhl3. Overall, our data suggest that defects in
Axd mutant embryos result from over-expression of Grhl2.
INTRODUCTION
Formation of the neural tube in higher vertebrates depends on
elevation, folding, apposition and fusion of the neural folds, a
process known as primary neurulation (1,2). Failure of this
process results in open neural tube defects (NTDs), which
are among the most common congenital malformations in
humans (3). Although there is strong evidence for a genetic
component in NTDs, identiﬁcation of the causative genes is
complicated by the fact that most cases appear to involve a
combination of genetic and environmental factors (4,5). The
large number of mouse genetic models in which NTDs
arise as part of the phenotype emphasize the possible
genetic complexity of these defects and provide insight into
the multiple molecular requirements for neural tube closure
(3,6,7).
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(spina biﬁda) occur at approximately equal frequency (8,9).
By comparison, a survey of the various NTD mutants in
mice reveals a striking predominance of models in which
cranial NTDs occur. Thus, exencephaly occurs in isolation
( 75% of mutants) or in combination with spina biﬁda
( 20% of mutants) in most models (7). In contrast, isolated
spina biﬁda is observed in only  5% of the roughly 250
mouse NTD mutants. Among NTDs induced by various tera-
togens, exencephaly is also induced more frequently than
spina biﬁda (10). Thus, cranial neural tube closure appears
exquisitely sensitive to disruption in mice. It may be that
cranial neural tube closure in the mouse embryo is more
complex than in humans, requiring coordinated function of
many gene products. Hence, there is a relative paucity of
mouse models for isolated spinal NTDs, despite the impor-
tance of these malformations in humans.
The Axial defects (Axd) mutation arose spontaneously in the
1980s and was recognized on the basis of a curled tail pheno-
type inherited as a semi-dominant Mendelian trait (11). The
penetrance of tail defects among Axd/+ mice varies with
genetic background, being highest on the BALB/c background
with  50–60% of mice affected (12). Intercrosses of hetero-
zygotes produced litters containing neonates with spina biﬁda,
presumed to be homozygous mutants (11). At embryonic day
(E) 12.5,  25% of embryos showed spina biﬁda, suggesting
that spinal NTDs are fully penetrant among homozygotes at
this stage (12). Cranial NTDs were not observed. Among neo-
nates, there was a lower incidence of curled tails and spina
biﬁda than expected. This was suggested to indicate possible
correction of tail defects and/or soft tissue healing over open
lesions during late gestation (11,12). However, inability to
genotype litters precluded further analysis of this possibility.
In the current study, we mapped the Axd mutation to a region
of chromosome 15 containing the grainyhead-like 2 (Grhl2)
gene, which encodes a transcription factor. We found that loss
of function of Grhl2 causes cranial and spinal NTDs, as pre-
viouslyobservedforGrhl3mutants(13–15).Expressionanaly-
sis in Axd mutant embryos showed over-expression of Grhl2,
whereas reduction of Grhl2 expression levels resulted in nor-
malization of spinal neural tube closure. We conclude that
both insufﬁcient and excessive expression of Grhl2 can cause
NTDs.
RESULTS
Axial defects mutant embryos display severe spina biﬁda
The phenotype of embryos among litters from Axd/+ inter-
crosses was examined by scanning electron microscopy (70
embryos) and light microscopy (.300 embryos), at develop-
mental stages during and after the stage of spinal neural
tube closure (E9.5–10.5 and later). Initial studies were per-
formed prior to linkage analysis, with the prediction that
embryos exhibiting failure of neural tube closure would corre-
spond to homozygous mutant embryos. These phenotype–
genotype correlations were conﬁrmed following mapping of
the Axd mutation (see what follows). Abnormalities in spinal
neural tube closure could be detected from around the 24
somite stage (E9.5), when homozygous Axd/Axd embryos
exhibited an enlarged posterior neuropore (PNP) compared
with wild-type littermates (Fig. 1A and B). The PNP (the
ﬁnal region of open spinal neural folds) is very small or
closed by the 31–32 somite stage (E10.5) in wild-type
embryos (Figs 1C and E, and 2C), whereas homozygous
mutants display very large open PNPs, of up to 3 mm in
length (Figs 1D and F, and 2C). The rostral limit of the
open PNP was at the level of somites 22–26, indicating that
closure had failed to progress beyond this axial level.
Examination of embryos at more advanced somite stages, at
E10.5 and E11.5, showed that the PNP of Axd mutants did not
reduceinsizebutremainedpersistentlyopen.Thisdefectcorre-
sponds to spina biﬁda, which can be readily visualized in
affected fetuses as a typical protrusion of tissue from the open
lesion at E16.5 (Fig. 1G). Transverse sections at the level of
the lesion reveal the degeneration of spinal cord tissue (Sup-
plementary Material, Fig. S1C and D). Damage appears most
severe at the sacral level where none of the typical architecture
of the neural tube can be discerned, whereas motor neurons are
still detectable in the lumbar region (Supplementary Material,
Fig.S1AandB).Bybirth,theexposednervoustissuehasdegen-
erated and the open vertebral arches are exposed at the dorsal
surface (Supplementary Material, Fig. S1E). Some fetuses
with spina biﬁda at E16.5 and 17.5 exhibit a ‘remnant’ of the
tail which we hypothesize to result from apparent degeneration
of the tail (Supplementary Material, Fig. S2D).
In the majority of heterozygous Axd/+ embryos, closure of
the PNP was complete by the 35 somite stage or soon after
(Fig. 2C). This reﬂects a delay in closure compared with wild-
type embryos, apparent as a higher mean PNP length in het-
erozygotes than wild-type littermates at the 26–28, 29–31
and 32–34 somite stages (P , 0.001). Delayed PNP closure
manifests at later stages as a tail ﬂexion defect or ‘curly tail’
in  40–50% of Axd/+ mice on the BALB/c background.
The Axd mutation maps to proximal chromosome 15
In order to map the mutation underlying the Axd phenotype, a
congenic strain was ﬁrst generated on the BALB/c genetic
background, selected for high penetrance of the dominant (het-
erozygous) phenotype (11). In the recombinant line, 97% of
alleles tested were homozygous BALB/c.
In order to map the Axd mutation, a cross was performed
between Axd males (on BALB/c background) and C57BL/6
females. Affected heterozygous offspring (recognized by the
presence of tail ﬂexion defects) were intercrossed to generate
litters in which embryos were isolated at E13.5. The rationale
of this approach was that the Axd mutation would remain
associated with the BALB/c genetic background, and not be
replaced by C57BL/6 genomic DNA in affected individuals.
Details of the linkage strategy are provided in the Supplemen-
tary Material. In summary, genomic DNA from 40 embryos
with open spina biﬁda was pooled and typed by PCR for
105 microsatellite markers that were polymorphic between
BALB/c and C57BL/6 and evenly spread over the autosomes
( 30 cM intervals). The involvement of the sex chromosomes
had previously been excluded (11). In the absence of linkage
to a genomic locus, a 1:1 ratio of BALB/c and C57BL/6
alleles would be expected in embryos with spina biﬁda.
Only chromosome 15 showed a divergence from the 1:1
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chromosome 15 and the spina biﬁda phenotype was further
investigated by individual analysis of affected embryos.
The Axd critical region was reﬁned using 40 additional infor-
mativemarkers(of100tested),whichrevealedapeakofBALB/
Figure 1. Failure of PNP closure in Axd mutant embryos. (A, C and E) Scan-
ning electron microscopy of wild-type embryos reveals that PNP closure has
progressed beyond the last formed somite and is at the level of the hindlimb
bud at the 24 somite stage (arrow in A); by the 31 somite stage (C and E),
the PNP has reduced in size to a small slit (arrow in E). (B, D and F) In con-
trast, Axd mutant embryos exhibit dramatically enlarged PNPs at both 26 and
31 somite stages (B and D, respectively), in which closure does not progress
beyond the level of somite 24 (arrow in B). At the 26 somite stage (B), the
neural folds of the mutant embryo appear elevated, although closure has not
progressed. By the 31 somite stage, the neural folds are splayed wide apart
(D and F). (G and H)I na nAxd mutant fetus at E16.5, open spina biﬁda is
evident (arrow in G) affecting the low thoracic, lumbar and sacral regions.
Transverse sections at the levels indicated by dashed lines in (G) are included
in Supplementary Material, Fig. S1. Scale bars: 500 mm (A–D), 100 mm (E),
200 mm (F), 2 mm (G) and 1 mm (H).
Figure 2. The Axd mutation maps to a critical region on mouse chromosome
15. (A) In DNA from embryos with spina biﬁda from an intercross of Axd and
C57BL/6 mice, typing of polymorphic markers showed a peak of BALB/c and
Axd alleles (non-C57BL/6) between D15Mit252 and D15Mit171 (22.6–
79.4 Mb). Within this region, a peak of Axd alleles (non-BALB/c or
C57BL/6) was present at 38.5–43.6 Mb. (B) Using additional novel poly-
morphic markers, a critical region of 1.1 Mb was deﬁned between markers
CA15–16 and CA15-05 (36.4–37.5 Mb). This region contains 10 known
genes (black boxes), as well as 3 RNA genes and various putative processed
transcripts (as of Ensembl release 60). The marker D15Mit250 showed
100% association of homozygosity for Axd alleles with spina biﬁda. (C)I n
embryos that were genotyped using D15Mit250, the PNP length was compared
at stages during and after spinal neural tube closure. The PNP fails to shorten
and close in homozygous Axd/Axd embryos (black circles), leading to spina
biﬁda. In contrast, most wild-type embryos exhibit closed PNPs by the 29–
31 somite stage (white circles) and Axd/+ embryos complete closure by the
35–37 somite stage in most cases (grey circles).
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D15Mit252 and D15Mit71 (22.6–79.4 Mb). Within a narrower
interval (38.5–43.6 Mb), 11 informative markers could
discriminate the Axd alleles from BALB/c and C57BL/6, con-
ﬁrming association (Fig. 2A). High-resolution mapping, using
a combination of additional D15Mit markers, novel poly-
morphic DNA markers based on nucleotide repeat sequences
andanadditionalcrosstoC57BL/6(generatingasecondrecom-
binantline),furthernarrowedthecriticalregiontoanintervalof
1.1 Mb (36.4–37.5 Mb) ﬂanked by heterozygous sequences
(Fig. 2B). A 100% association was observed between homozy-
gous Axd alleles for D15Mit250 (at 36.7 cM) and the presence
of a large PNP (n . 150 embryos) in embryos at E10.5
(Fig. 2C). Therefore, in subsequent experiments, this marker
was used to genotype embryos from heterozygous Axd inter-
crosses on the BALB/c background.
Grhl2 is over-expressed in Axd mutant embryos
The Axd critical region harbours 10 protein-coding genes
(Fig. 2B) and three RNA genes (AC137871.1, AC114008.1
and AC121814.1) encoding micro-RNA or non-coding
RNA, as well as three loci encoding putative processed tran-
scripts (as at Ensembl release 60). The corresponding human
syntenic region is at chromosome 8q22. The coding regions
and intron–exon boundaries of Ankrd46, Pabpc1, Ywhaz,
Zfp706, Grhl2 and Ncald were sequenced and no mutations
were detected (data not shown). In order to investigate the
possibility that a regulatory mutation might result in abnor-
mal expression of one of these Axd candidate genes,
expression levels were analysed by quantitative real-time
RT–PCR (qRT–PCR). A series of embryos at stages
during and immediately after spinal neurulation were
selected that either displayed a large PNP or spina biﬁda
and genotyped as Axd/Axd (n ¼ 14) or had a normal or
closed PNP and typed as wild-type (n ¼ 9). The expression
of Grhl2 showed marked up-regulation in Axd/Axd
embryos, with an overall expression elevation of  2.5-fold
(P , 0.001, Mann–Whitney rank sum test) and a peak at
the 30–35 somite stage, when up to 5-fold increase in
expression was observed (Fig. 3A). None of the other ﬁve
candidate genes analysed showed a signiﬁcant difference in
Figure 3. Expression of Grhl2 is elevated in Axd mutant embryos. (A and B) Expression analysis by qRT–PCR using mRNA extracted from whole embryos (A)
and isolated caudal regions (B), at the 30–31 somite stage. There is signiﬁcant up-regulation of Grhl2 expression in Axd/Axd embryos compared with wild-type
littermates, particularly from the 25 somite stage onwards (A). Heterozygous embryos exhibit an intermediate level of Grhl2 expression in the caudal region (B),
whereas no difference in expression was observed for the remaining genes in the Axd critical region. (C–F) Whole-mount in situ hybridization for Grhl2
consistently shows more intense staining in intact Axd/Axd embryos (D) compared with wild-type controls (C). Sites of expression include the otic vesicle
(white arrowhead in C), pharyngeal region (white arrowhead in D) and forebrain (black arrowhead in D). Sections through the caudal region (at the levelo f
the dotted lines in C and D) reveal expression of Grhl2 in the hindgut endoderm, whereas the neural folds are negative (E and F). Note the more intense
hindgut expression in the Axd/Axd embryo (F) with apparent ectopic expression in mesoderm lateral to the hindgut, which is not observed in wild-type (E).
Scale bars: 1 mm (C and D) and 0.1 mm (E and F).
Human Molecular Genetics, 2011, Vol. 20, No. 8 1539expression between mutant and wild-type embryos
(Supplementary Material, Fig. S3).
We further analysed mRNA levels in the isolated caudal
regions of a separate series of 30–31 somite stage
embryos to focus on the embryonic region undergoing
spinal neurulation (Fig. 3B). This analysis showed that
Grhl2 expression is signiﬁcantly elevated, by  4-fold, in
homozygous mutants, while heterozygotes exhibit a level
intermediate between +/+ and Axd/Axd (Fig. 3B). In con-
trast, expression of the other genes in the critical region
did not vary with genotype. Together, these studies demon-
strate that up-regulation of Grhl2 correlates with failure of
PNP closure in Axd/Axd embryos. Indeed, this can be visu-
alized by plotting the PNP length against relative expression
of Grhl2 which demonstrates an approximately linear
relationship over at least a 5-fold range of Grhl2 levels
(Supplementary Material, Fig. S4). Whole-mount in situ
hybridization for Grhl2 showed markedly more intense stain-
ing in Axd/Axd embryos compared with wild-type or hetero-
zygous littermates (Fig. 3C–F), including in the pharyngeal
region, otic vesicles, forebrain and hindgut. Therefore, Axd/
Axd embryos appear to exhibit an up-regulation of Grhl2 at
all sites of expression.
Grhl2 has close homology and shares a consensus-binding
sequence with Grhl3 (16,17), whose loss of function following
gene targeting or down-regulation in the curly tail mutant
results in spina biﬁda (13–15). Delayed eyelid closure has
been noted in Grhl3 mutant mice, with closure not completed
in any Grhl3 null fetuses by E16.5 compared with 100%
closure in wild-type (18). Similarly, we noted lack of eyelid
closure at E16.5 in Axd/Axd mutants (seven out of seven;
Fig. 1G and Supplementary Material Fig. S2), whereas
closure was complete in all wild-type and heterozygous
fetuses examined (0 out of 11 with open eyelids).
Generation of a loss of function allele of Grhl2
We hypothesized that Axd represents a hypermorphic (over-
expressing) allele of Grhl2 based on linkage analysis,
up-regulation of expression at the stage of spinal neurulation
and phenotypic similarities to Grhl3 mutants. We reasoned
that if excess expression of Grhl2 is responsible for NTDs in
the Axd model, then reduction of expression should normalize
spinal neurulation. In order to test this idea genetically, we gen-
erated a loss of function allele, using a gene-trap of Grhl2
(Sanger Institute Gene Trap Resource, cell line AC0205).
This allele carries the pGT0Ixr trap vector in intron 14
(Fig.4A).TheGrhl2
GTallele,therefore,generatesafusiontran-
Figure 4. A gene-trap allele of Grhl2 results in NTDs. (A) The gene-trap
vector is inserted in intron 14 of the Grhl2 gene. Schematics of wild-type
allele (top) and b-geo-containing gene-trap allele (bottom). F1, F2, R1, R2:
PCR primers. Grey bars: exons. (B) Efﬁcacy of gene-trapping was conﬁrmed
by RT–PCR using cDNA generated from Grhl2
GT/+ (lanes 1–4) and +/+
(lanes 6–9) embryos (lanes 5 and 10 are no RT controls). Primer pairs that
span exons 13–16 (F1 and R2; lanes 4 and 9) or exons 14–16 (F2 and R2;
lanes 2 and 7) amplify the wild-type transcript from both +/+ and
Grhl2
GT/+ embryos, whereas the trapped allele (ampliﬁed by primer F1
or F2 with R1) was detected only in Grhl2
GT/+ samples (lanes 1 and 3).
(C–F) X-Gal staining of Grhl2
GT/+ embryos on the C57BL background,
shown in side view (C and D), ventral view (E) and sectioned at the level
of the dashed line in (C) (F). Efﬁcacy of gene-trapping is conﬁrmed, as is
the Grhl2 expression pattern which closely resembles that observed by whole-
mount in situ hybridization (Fig. 3). Note expression in hindgut (arrows in C
and D), branchial arches (ba), nasal pit (np) and Rathke’s pouch (white arrow-
head in E), otic vesicles (ov), foregut (arrows) and ectoderm lining the limb
buds (arrowheads in F). In some heterozygous embryos on the C57BL back-
ground, we observed exencephaly with ‘split face’ (EX in D). (G and H)
On the BALB/c background, exencephaly with split face was observed
together with spina biﬁda (SB: neural folds open to the level of arrowhead
in H) in homozygous Grhl2
GT/GT embryos (H), whereas heterozygotes were
usually normal (G). Scale bars: 1 mm in all panels, except (F) (0.5 mm).
1540 Human Molecular Genetics, 2011, Vol. 20, No. 8script lacking exons 15 and 16, which encode the 59 C-terminal
amino acids of the Grhl2 protein (full-length protein is 625
amino acids). The location of the gene-trap vector was deter-
mined by PCR using combinations of intronic and vector
primers. Sequencing of PCR products showed that the insertion
sitewas at6611 bpofthe10 515 bpintron14.Efﬁcacy ofgene-
trapping was conﬁrmed by RT–PCR and X-Gal staining of
embryonic stem cell colonies (not shown) and heterozygous
embryos (Fig. 4), exploiting the expression of b-geo from the
trapped allele. Staining was evident in several ectodermal
locations, mimicking the Grhl2 expression pattern obtained
by in situ hybridization. Sites included the surface ectoderm
lining the branchial arches and limb buds, oral ectoderm,
nasal pits, otic vesicles and Rathke’s pouch (Fig. 4C–F; Sup-
plementary Material, Fig. S5).
Among heterozygous Grhl2
GT/+ embryos analysed at
E9.5–10.5, we observed a low frequency of cranial NTDs
(15%; 11 out of 75 embryos) that was not observed among
wild-type littermates. The cranial NTD phenotype involves
failure of closure of the neural folds in the forebrain (‘split
face’) and throughout the midbrain (Fig. 4D). In initial exper-
iments, we did not recover homozygous embryos at stages
later than E9.5 from intercrosses of heterozygotes, on a
mixed 129/Sv and C57Bl/6 background. However, once the
Grhl2
GT allele was backcrossed onto a BALB/c background
for two generations (prior to intercross to Axd, see below),
homozygous mutant (Grhl2
GT/GT) embryos could be recov-
ered at E10.5 and these embryos exhibited not only severe
exencephaly with ‘split face’ but also spina biﬁda
(Fig. 4H). Cranial NTDs occurred with 100% penetrance
(17 out of 17 homozygotes at E10.5–11.5), and spina
biﬁda occurred in 88% of homozygotes. These ﬁndings
suggest a key requirement for Grhl2 in neural tube closure
at both rostral and caudal levels of the body axis. The
NTD phenotypes that we observed in Grhl2
GT mutant
embryos resemble those recently reported in Grhl2 knock-out
mice (17), suggesting that the Grhl2
GT allele corresponds to a
loss of function.
Normalization of PNP closure in Axd embryos by loss of
Grhl2 function
In order to test the hypothesis that over-expression of Grhl2
causes spinal NTDs in Axd mutant mice, we crossed Axd/+
and Grhl2
GT/+ mice to generate Axd/Grhl2
GT compound het-
erozygotes. To provide a quantitative measure of the degree to
which spinal neurulation is affected by genotype, the length of
the PNP was analysed with respect to developmental stage
(Fig. 5A). Spinal neurulation was complete, signiﬁed by com-
plete closure of the PNP, in the majority of +/+ and
Grhl2
GT/+ embryos by the 31 somite stage. In contrast, the
mean PNP length in Axd/+ embryos was signiﬁcantly larger
than in wild-type, with closure not occurring until after the
34 somite stage. The delayed closure of the PNP is likely
responsible for the tail ﬂexion defects observed in heterozy-
gous animals. Among Axd/Grhl2
GT embryos, there was an
overall signiﬁcant reduction in the mean PNP length compared
with Axd/+ embryos at the 30–31 and 32–34 somite stages
(Fig. 5A). Thus, although the presence of the Grhl2
GT allele
did not rescue the Axd heterozygous phenotype in every
Axd/Grhl2
GT embryo, there was a striking shift towards
smaller PNP lengths compared with stage-matched Axd/+
embryos. Moreover, 6 out of 35 Axd/Grhl2
GT embryos had
Figure 5. Spinal neural tube closure in Axd and Grhl2
GT compound heterozy-
gotes. (A) The length of the PNP (the open region of spinal neural folds) was
assessed in relation to developmental stage (as determined by the number of
somites) in E10.5 embryos from crosses between Axd/+ and Grhl2
GT/+
mice. Mean PNP length was signiﬁcantly greater in Axd/+ embryos than all
other genotypes at the 30–34 somite stages (∗P , 0.001, one-way
ANOVA). Axd/Grhl2
GT embryos (blue circles) had signiﬁcantly longer
PNPs than Grhl2
GT/+ (grey circles) or +/+ (green circles) littermates (P ,
0.001). (B) Expression analysis of isolated caudal regions at the 30–32
somite stage, using qRT–PCR. Expression of the full-length Grhl2 transcript
(left side of graph) is greater in Axd/+ embryos compared with all other gen-
otypes (∗P , 0.005, one-way ANOVA). Expression was also elevated in Axd/
Grhl2
GT samples compared with Grhl2
GT/+ reﬂecting the functional differ-
ence between the wild-type and Axd mutant alleles (
#P , 0.005). Combined
analysis of the full-length and trapped transcripts (right side of graph)
shows increased expression in Axd/+ samples compared with +/+ or
Grhl2
GT/+ (∗∗P , 0.05). Axd/+ and Axd/Grhl2
GT samples do not differ in
expression, since the trapped and full-length transcripts are expressed at
similar levels.
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whereas this did not occur in any of the 17 Axd /+ embryos
examined at these stages. Thus, reduction of Grhl2 expression
level acts to normalize PNP closure in Axd/+ embryos.
To evaluate the relationship between Grhl2 expression
level and PNP closure, the caudal region was isolated from
a series of embryos and subjected to qRT–PCR for Grhl2,
using primers (in exons 14 and 16) that amplify the full-
length but not the gene-trapped transcript (Fig. 5B). Grhl2
expression was signiﬁcantly elevated in Axd/+ embryos com-
pared with +/+ embryos, whereas expression in Axd/
Grhl2
GT embryos was comparable with wild-type and signiﬁ-
cantly lower than in Axd/+ embryos. Interestingly, qRT–
PCR, using primers in exons 10 and 11, which amplify
both the full-length and gene-trapped transcripts, showed
that ‘total’ Grhl2 expression was comparable in Axd/
Grhl2
GT and Axd/+ embryos (Fig. 5B). Thus, normalization
of PNP closure correlates with reduction of expression
levels of the full-length Grhl2 transcript, but not the short
transcript encoding exons 1–14.
Over-expression of Grhl2 in the hindgut may contribute to
increased curvature and altered proliferation in the caudal
region
The Grhl2 expression pattern was determined both by whole-
mount in situ hybridization (Fig. 3) and by X-Gal staining
(Fig. 4). In the caudal region, the site of spinal neurulation,
expression was not detected in the neuroepithelium but
intense staining was evident ventral to the neural tube. Trans-
verse sections through the caudal region conﬁrmed that this
tissue corresponds to the hindgut (Figs 3E and F, and 6A–
C). Detection of Grhl2 in the hindgut at E10.5, but apparently
not in the neural folds, is reminiscent of Grhl3 expression (15)
and suggests that failure of neural tube closure in Axd mutant
embryos results from a defect in a non-neural tissue.
In curly tail (ct/ct) mice, reduced expression of Grhl3 in the
hindgut results in diminished cellular proliferation and conse-
quently increased ventral curvature that mechanically opposes
PNP closure (19,20). The possibility that a similar mechanism
might contribute to spinal NTDs in Axd mice was raised by the
fact that embryos with a large open PNP at E10.5, sub-
sequently genotyped as Axd/Axd, were frequently noted to
exhibit abnormal ventral curvature of the caudal region
(Fig. 6D–E). Measurements of the caudal region in a series
of embryos at E10.5 showed that the angle of curvature of
the caudal region was indeed signiﬁcantly greater in Axd
homozygous mutant embryos than in wild-type or heterozy-
gous littermates (Fig. 6F).
We next investigated whether the increased ventral curva-
ture of Axd/Axd embryos could result from a proliferation
imbalance in the caudal region, as in curly tail mutants. Immu-
nostaining for phospho-histone H3 on transverse sections
through the caudal region revealed a signiﬁcantly lower
mitotic index in the hindgut endoderm of Axd/Axd compared
with wild-type embryos at the 23–28 and 31–33 somite
stages (Fig. 6G and H). A small but signiﬁcant difference in
the mitotic index was also noted in the neural folds
(Fig. 6G) at the earlier stage but not at the 31–33 somite
stage, the stage at which spinal neurulation should be
approaching completion (Fig. 6H).
Since spinal NTDs occur in association with altered
expression of Grhl genes in both curly tail and Axd mutants
and have phenotypic similarities, we tested whether the ct
and Axd mutations interact genetically. Homozygous ct/ct
mice were crossed with Axd/+ heterozygotes and the
Figure 6. Increased ventral curvature and diminished hindgut cell proliferation
in Axd mutant embryos. (A–C) In the caudal region of E10.5 Grhl2
GT/+
(A and B) and Grhl2
GT/GT (C) embryos, X-Gal staining is detected in the
hindgut underlying the PNP region (sections in B and C at the level of the
dotted line in A). Note staining also in surface ectoderm. The open neural
folds in the Grhl2
GT/GT embryo (C) correspond to failure of spinal neurulation
in this genotype. (D–F) Ventral curvature of the caudal region appears greater
in Axd/Axd embryos (E) than in wild-type littermates (D). Quantitation of
ventral curvature (angle between lines a and b in A) in a series of 27–33
somite stage embryos at E10.5. Axd/Axd embryos (n ¼ 10) have signiﬁcantly
greater caudal curvature than either +/+ (n ¼ 10) or Axd/+ (n ¼ 18) litter-
mates (∗P , 0.001, one-way ANOVA). Mean somite number did not differ
between genotypes (+/+, 31.1+0.5; Axd/+, 30.9+0.5; Axd/Axd, 30.6+
0.6). (G and H) Mitotic index in the hindgut endoderm and neuroepithelium
of E10.5 embryos at 23–28 somite stage (G) and 31–33 somite stage (H).
Hindgut proliferation is reduced in Axd/Axd embryos compared with +/+ lit-
termates at both stages (∗P , 0.05). A smaller but signiﬁcant difference in
mitotic index was also observed in the neuroepithelium at 23–28 somites
but not at 31–33 somites. Analysis based on transverse sections at the level
of the PNP immunostained for phospho-histone H3. Scale bars: 1 mm in
(A), 0.1 mm in (B) and (C) and 0.5 mm in (D) and (E).
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2.5-fold increased frequency of curled tails among
ct/+;Axd/+ mice compared with ct/+;+/+ (n ¼ 32; P ¼
0.03; two-tailed Fisher’s exact probability test), suggesting
that the Axd and ct mutations can genetically interact,
leading to delay of spinal neural tube closure.
DISCUSSION
The relative paucity of mouse models for isolated spina biﬁda
presents a challenge in identifying candidate genes for the cor-
responding defects in humans. A parallel hypothesis could be
that the genetic aetiology of human spina biﬁda will prove less
complex than anencephaly, in which many more genes are
potentially implicated from mouse models.
In the current study, we provide evidence that over-
expression of Grhl2 is the cause of spina biﬁda in Axd
mutant mice. Although the Axd mutation has not yet been
characterized, several lines of evidence support a primary
role for Grhl2 in the Axd phenotype. First, Grhl2 is located
in the Axd critical region and exhibits misregulated expression
in association with failure of spinal neurulation. Second, Grhl2
is over-expressed in the surface ectoderm and hindgut of Axd/
Axd embryos, both tissues that have been functionally impli-
cated in NTDs in other models (3). Third, we ﬁnd that loss
of function of Grhl2, as well as Grhl3, causes NTDs, implicat-
ing this gene family in neural tube closure (17,21,22). Fourth,
Axd mutants show eyelid fusion defects reminiscent of those
observed in Grhl3 mutants (18). Finally, delayed closure of
the PNP in embryos that are heterozygous for the Axd allele
can be ameliorated by reduction of Grhl2 function, following
replacement of the wild-type allele with a Grhl2
GT allele.
As we could not identify a coding region mutation in Grhl2
in Axd mutants, we carried out additional sequencing of the 5′
and 3′ UTRs including 1.6 kb upstream of the start codon (at
chromosome 15: 37 163 142) and a conserved 5′ region
(37 111 871–37 112 536). This did not reveal any difference
to the mouse genomic sequence database (UCSC Genome
Browser). Nevertheless, we hypothesize that the Axd pheno-
type results from a regulatory mutation which leads to
increased expression of Grhl2. Knock-in of Grhl2 into the
Grhl3 locus has recently been found to generate embryos
with spina biﬁda which resemble Grhl3 null mutants (17).
This was interpreted to indicate that Grhl2 is unable to com-
pensate for the function of Grhl3 in spinal neural tube
closure (17). An alternative explanation, however, is that over-
expression of Grhl2 might have contributed to development of
spinal NTDs in these knock-in embryos, as in Axd.
Grhl2 functions as a transcription factor (23), and failure
of neural tube closure presumably results from misregulation
of key downstream genes. The ﬁnding of a similar spina
biﬁda phenotype following over-expression or knock-out of
Grhl2 raises questions about the underlying molecular mech-
anisms and whether the same downstream targets are impli-
cated in each model. In contrast to the spinal neural tube,
cranial neurulation appears unaffected by the Axd mutation,
whereas Grhl2 null embryos display a severe phenotype
with complete absence of closure in fore- and midbrain.
This discrepancy could suggest that differing mechanisms
underlie NTDs, including spina biﬁda, in Axd and Grhl2
null embryos. Alternatively, the key Grhl2 target genes
might differ between cranial and spinal regions and those
that are essential in the cranial region may be resistant to
excessive Grhl2 levels.
Certain features of Axd resemble the known pathogenesis in
curly tail mutant embryos, in which reduced expression of
Grhl3 in the hindgut leads to diminished proliferation and
enhanced ventral curvature of the caudal region of the
embryo (21). Grhl2 is also expressed in the hindgut and we
ﬁnd diminished proliferation in this tissue along with
increased ventral curvature of the caudal region. We hypoth-
esize that this curvature may contribute to development of
spinal NTDs through mechanical inhibition of closure as in
curly tail. Grhl2 and Grhl3 can form heterodimers as well as
homodimers (24), and we speculate that the presence of
increased levels of Grhl2 could favour formation of heterodi-
mers in Axd mutants at the expense of Grhl3 homodimers.
Such an effect could lead to suppression of Grhl3 function,
thereby mimicking the Grhl3 hypomorph, curly tail. Indeed,
we do observe genetic interaction in double heterozygotes
for the Axd and ct mutations.
Partial penetrance among mouse models of NTDs offers the
opportunity to investigate gene–environment interactions and
possible prevention of defects by exogenous agents. Spinal
NTDs in curly tail mice can be partially ameliorated by
exposure to retinoic acid, but in vivo treatment of Axd/+
dams did not alter the frequency of NTDs among litters (25).
In contrast, methionine supplementation at neurulation stages,
which is ineffective in curly tail (26), was found to reduce the
frequencyof spina biﬁda inAxd litters although alow incidence
of exencephaly was also observed (12). A possible association
between elevated methionine and cranial NTDs is consistent
with ﬁndings from embryo culture studies in wild-type mice
(27). It will be of interest to determine whether effects of meth-
ioninetreatmentonneuraltubeclosureinAxdisassociatedwith
alteration in expression of Grhl2. For example, reduced
expression of Grhl2 could be associated with normalization of
spinal neurulation in Axd/Axd embryos but with induction of
cranial NTDs in wild-type embryos.
In humans, GRHL2 has been implicated in age-related
hearing impairment (28), with the identiﬁcation of a GRHL2
mutation in autosomal dominant non-syndromic hearing loss
(29). These conditions are thought to relate to expression of
Grhl2 in the otic vesicle (as we also observe in mice) and
the cochlea later in development (29). In the current study,
our ﬁndings suggest that either loss or gain of function of
Grhl2 can cause spina biﬁda in the mouse, suggesting a key
requirement for regulation of Grhl2 during spinal neurulation.
Moreover, loss of function models demonstrate a critical
requirement for Grhl2 in cranial neural tube closure, including
in the forebrain (current study and reference 17). These studies
implicate Grhl2 as a candidate gene for NTDs in humans. It is
striking that presumed regulatory mutations affecting
expression of both Grhl2 (Axd; current study) and Grhl3
(curly tail; reference 15) have now been found to result in
spinal NTDs, perhaps emphasizing the need to consider regu-
latory as well as missense mutations in searching for the genes
contributing to human NTDs.
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Mouse strains
Axd mice were obtained upon rederivation of cryopreserved
embryos from Rutgers University, NJ, USA. These mice had
a mixed genetic background including the original Axd
strain (of unknown origin), BALB/c, C57BL/6 and C3H/
HeN. Affected heterozygous Axd mice were backcrossed mul-
tiple times to BALB/c (BALB/cAnNCrl; Charles River) to
obtain a congenic strain while monitoring the genetic back-
ground using polymorphic microsatellite markers. For
linkage analysis, congenic mice were crossed with C57BL/6
(C57BL/6NCrl; Charles River) and then intercrossed to
obtain litters which were analysed at E13.5 for the presence
of open spina biﬁda (see Supplementary Materials for details
of linkage analysis). Initially, the Axd strain (AxBR3) was
maintained by a breeding scheme in which heterozygous
mice (determined by a curled tail phenotype) were mated
with wild-type mice (determined by a lack of phenotype in
three subsequent crosses). Following linkage analysis, mice
and embryos were genotyped using the D15Mit250 poly-
morphic marker, which lies between Pabpc1 and Ywhaz.
For generation of mice carrying a gene-trap allele of Grhl2
(denoted Grhl2
GT), the AC0205 embryonic stem cell line, car-
rying the pGT01xr vector inserted in intron 14 of Grhl2, was
obtained from the International Gene Trap Consortium. Chi-
meric mice carrying the Grhl2
GT allele were generated by
blastocyst injection of ES cells (UCL Institute of Child
Health ES Cell Facility), and chimeras were mated to
C57Bl/6 to test for germline transmission and establish a
colony of heterozygous mice. Efﬁcacy of the gene-trap
vector and targeting of Grhl2 were conﬁrmed by X-Gal stain-
ing of ES cells and embryos and sequencing of RT–PCR pro-
ducts, generated using a forward primer in exon 14 of Grhl2,
with a reverse primer in the trap vector (see what follows for
RT–PCR details; sequence of primers available on request).
The gene-trap vector insertion site was localized in intron 14
using a series of 20 primer pairs designed against the intron
in combination with vector-speciﬁc primers. This allowed
design of a genotyping strategy based on PCR of genomic
DNA (see Supplementary Material).
Sequence analysis
Overlapping DNA fragments were ampliﬁed by PCR from
pools of genomic DNA prepared from three E10.5 embryos
with open spina biﬁda and three wild-type embryos. Primer
sequences are available on request. PCR products were puri-
ﬁed (GenElute PCR Clean-up Kit, Sigma) and used as tem-
plate for cycle-sequencing reactions (Applied Biosystems,
Big Dye Terminator), which were analysed with an ABI
PRISM 3100 Genetic Analyzer (Applied Biosystems).
Collection of embryos and X-Gal staining
Embryoswere obtained fromtimedmatings: noononthe dayof
ﬁnding a copulation plug was designated 0.5 days of embryonic
development (E0.5). Pregnant females were killed by cervical
dislocationandembryosweredissectedfromtheuterusinphos-
phate buffered saline (PBS) or Dulbecco’s modiﬁed Eagle’s
medium containing 10% fetal calf serum. Embryos designated
for DNA/RNA isolation were snap-frozen in liquid nitrogen
or dry ice and stored at 2808C. Embryos for in situ hybridiz-
ationorhistologicalanalysiswerewashedindiethylpyrocarbo-
nate (DEPC)-treated PBS and ﬁxed in 4% paraformaldehyde
(PFA) in DEPC-PBS at 48C overnight, or in Bouin’s ﬂuid at
room temperature for several days.
Embryos for X-Gal staining were ﬁxed in ice-cold 0.2%
glutaraldehyde in PBS, rinsed in PBS and incubated in
staining solution: 1× PBS, 2 mM MgCl2,2 0 m M Tris–HCl
(pH 7), 0.2% NP40, 10 mM K3Fe(CN)6,1 0 m M
K4Fe(CN)6.H2O with X-gal (100 mg/ml in dimethyl sulfoxide)
as a 1:50 (v:v) addition at 378C overnight. Embryos were
re-ﬁxed in 4% PFA at 48C, dehydrated to methanol and
stored at 2208C prior to embedding in parafﬁn wax, section-
ing at 5 mm thickness and counter staining with eosin.
Whole-mount in situ hybridization and
immunohistochemistry
Whole-mount in situ hybridization was performed as described
previously (15), using a digoxygenin-labelled cRNA probe
which was complementary to nucleotides 366–1217 of the
Grhl2 transcript (NM_026496). Embryos were embedded in
gelatine-albumin and sectioned at 50 mm thickness on a vibra-
tome, as described previously (30).
Embryos were embedded in parafﬁn wax and 7 mm trans-
verse sections were immunostained for phospho-histone H3
(Upstate Biotechnology). Sections through the caudal region
were matched for axial level using the hindlimb bud as mor-
phological landmark (14). Mitotic index was calculated for
neuroepithelium and hindgut in each section based on the
number of stained cells expressed as a percentage of the
total number of cells (as determined by number of
DAPI-stained nuclei), as described previously (15,31).
Scanning electron microscopy
Embryos were ﬁxed in Bodian’s ﬂuid [90 ml of ethanol (80%),
5 ml of acetic acid (99%) and 5 ml of formaldehyde (37%)] and
prepared for scanning electron microscopy. After ethanol
dehydration, they were critical-point-dried using liquid CO2,
attached to aluminium stubs with silver paint, coated with
gold/palladium and viewed at 10 kV with a Philips-XL30 scan-
ning electron microscope (SEM).
RNA isolation, cDNA synthesis and real-time qRT–PCR
ForanalysisofthesixcandidategenesintheAxdcriticalregion,
total RNA was isolated from affected (AxBR4CR1F2), wild-
type (AxBR3F2) and BALB/c embryos at 25–43 somite stage
(E10.5), using TRI Reagent (Invitrogen) and subsequently pur-
iﬁed (RNeasy, Qiagen). First-strand cDNA synthesis was per-
formed according to the manufacturer’s instructions (iScript
cDNASynthesisKit,BioRad).Relativeexpressionofcandidate
genes was analysed by qRT–PCR using an iQTM5 Real-Time
PCR Detection System (Bio-Rad) with iQ SYBR Green Super-
mix (Bio-Rad). Primers, which spanned exons, were designed
using Primer Express 1.5 software (ABI) based on the sequence
entries in GenBank (Supplementary Material, Table S2).
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(Gapdh) and ribosomal RNA 18S (18S) were used as reference
genes. Multiple wild-type and affected samples were tested
simultaneously. Sample duplicates differing by more than 0.5
in Ct value were excluded. Values were determined using Lin-
RegPCR,analysisofreal-timedata,version9.30beta.Between-
session variation was accounted for using the Factor Correction
program (32).
For further analysis of Grhl2 expression in Axd and Axd/
Grhl2
GT embryos, RNA was puriﬁed from isolated caudal
regions (cut at the level of somite 21), genomic DNA
removed by DNase I digestion (DNA-free, Ambion) and ﬁrst-
strand cDNA synthesis performed (SuperScript VILO cDNA
Synthesis Kit, Invitrogen). qRT–PCR was performed
(MESA Blue Mastermix for SYBR Assay, Eurogentec) on a
7500 Fast Real-Time PCR System (Applied Biosystems),
with each sample analysed in triplicate. Primers were designed
to amplify exons 10–14 and 14–16 of the mouse Grhl2 cDNA
(Supplementary Material, Table S2), and results were normal-
ized to Gapdh as previously (15).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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